FDA confirms end of Eli Lilly’s tirzepatide shortage after re-evaluation
The FDA declared the tirzepatide shortage over in October 2023, but a lawsuit by Outsourcing Facilities Association, a trade ...
The Washington Post5m
The conservative policy shop helping shape GOP priorities
The newsletter once known as “The Health 202” was launched 2,782 days ago, as President Donald Trump and his congressional allies attempted to repeal the Affordable Care Act. (It didn’t go well.) ...